Johnson & Johnson Medtech Partners with Qure.ai to Boost Early Detection of Lung Cancer in India
This initiative is part of Project BreatheEZ, a broader strategic collaboration between Qure.ai and Johnson & Johnson MedTech, and designed to establish AI-led Incidental Pulmonary Nodule (IPN) Detection clinics across leading hospitals in India. These clinics will act as integrated screening hubs, optimizing early detection, triaging, and follow-up care for lung cancer patients. As part of this collaboration, Qure.ai's AI technology will be deployed across 10 hub medical centers in India, with an additional 20 supporting spoke sites. The first such clinic has been launched in Thangam Cancer Centre in Namakkal, Tamil Nadu.
In India, one in nine persons is likely to be diagnosed with cancer in their lifetime. It is an increasing health concern, and the projected cancer burden is expected to rise from 26.7 million DALYs (Disability-Adjusted Life Years) in 2021 to 29.8 million in 2025¹. This growing health challenge needs innovative solutions to improve early detection and ultimately save lives. Traditional diagnostic methods often fail to detect lung cancer at an early stage, leading to delays in treatment. Thus, this collaboration between Johnson & Johnson MedTech and Qure.ai marks a significant leap forward.
By harnessing of artificial intelligence in the modalities of X-Ray & CT scans, Johnson & Johnson MedTech India & Qure.ai are enabling the detection of potential lung nodules that might otherwise be missed. This happens through flagging risky nodules in X-Rays and CT Scans that can potentially turn out to be malignant. It also introduces the concept of structured IPN clinics where there is a proactive impetus towards incidental screening of early-stage lung cancer. This partnership embodies Johnson & Johnson MedTech's commitment to enhancing early lung cancer detection, ultimately transforming the standard of lung cancer care.
Anuj Virmani, Managing Director, India, Johnson & Johnson MedTech, said, 'Lung cancer continues to be one of the leading causes of cancer in both men and women. In India, where access to advanced healthcare facilities is often limited, especially in tier-2 and tier-3 cities, patients face significant challenges in receiving timely and effective diagnosis, which further delays access to treatment. Our collaboration with Qure.ai is a testament to our commitment to advancing healthcare through innovative solutions continues to drive impactful collaborations and integrating our solutions in lung cancer.'
Reference:
1. ICMR and NCDIR World Cancer Day 2024, Close the care gap- Addressing cancer care in India, 04th – February – 2024 https://ncdirindia.org/display/wcd.aspx.
Surgical Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world's most complex and pervasive health challenges. For over 100 years, we have helped advance surgical care through our innovative portfolio across wound closure, adjunctive hemostats, surgical stapling and instruments, robotics and digital solutions. Together, with clinicians and healthcare experts around the world we are progressing what's next in surgery to better solve patient needs in metabolic and cardiovascular disease, cancer, and aesthetics and reconstruction. For more, visit https://www.jnj.com/medtech#surgery.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by BusinessWire India. ANI will not be responsible in any way for the content of the same)
This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
Boston Scientific lifts annual profit forecast, sees smaller tariff impact
Bengaluru: Boston Scientific raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices , and trimmed its expectation for tariff-related costs to half of the previously projected amount. Shares of the company rose 4.8% in morning trading following the results. "Based on the current schedule of expected tariffs, we now anticipate a full-year headwind of about $100 million, down from a $200 million estimate," CFO John Monson said during a call with analysts. The company expects to offset the remaining tariff impact through strong sales performance, favorable product mix and spending control, Monson added. A rise in surgical procedures has boosted sales for medical device makers such as Boston Scientific, helping counter broader concerns about healthcare spending. Executives credited strong trial results and expanded product indications for fueling physician adoption of key cardiovascular devices such as Watchman and Farapulse, the firm's main growth drivers that saw steady quarterly demand. The company said the proposed rules by the Centers for Medicare & Medicaid Services regarding certain cardiac procedures would further benefit its technologies. Farapulse, which is approved in the U.S. for some patients with intermittent atrial fibrillation, competes with Johnson & Johnson's Varipulse and Medtronic's PulseSelect in the pulsed field ablation (PFA) market. Rival Johnson & Johnson last week posted strong medtech sales, aided by its heart devices, Varipulse and Trupulse. JP Morgan analyst Robbie Marcus said the profit forecast raise was larger than many had expected, especially given Boston Scientific is now moving past the initial U.S. rollout of Farapulse. "That said, the outlook still appears conservative to us," Marcus added. Boston Scientific now expects 2025 adjusted profit of $2.95 to $2.99 per share, up from its prior view of $2.87 to $2.94.
Economic Times
a day ago
- Economic Times
Will Bryan Johnson never die? Here's all about tech entrepreneur's tall claim, Bryan AI and Project Blueprint
Agencies Bryan Johnson discusses brain-computer technology, age reversal, and Bryan AI as part of his goal to outlive biology. Will Bryan Johnson never die? The founder of Braintree and Kernel has made a bold statement about his future. In a recent WIRED interview, Johnson said he does not believe he will die. This statement is not based on belief alone but on scientific projects he is funding and leading. His work combines artificial intelligence, biology, and neuroscience to develop a new understanding of life and believes that human identity can move beyond biology. He is developing Bryan AI, a digital version of himself. This system is being trained using thousands of hours of his recorded conversations, writings, interviews, and thoughts. According to Johnson, Bryan AI will: Think like him Respond like him Hold his values and memory Serve as a digital twin This project reflects Johnson's idea that a person's consciousness can live beyond the body. He sees Bryan AI as a second version of himself, stored digitally and able to evolve independently. Also Read: Bruce Willis Net Worth 2025: Who manages actor's estate? See his film earnings, endorsements, royalties and wealth Johnson's personal health project, known as Project Blueprint, costs around $2 million per year. It focuses on reversing biological aging and is supported by a large medical team. Key features of his lifestyle include: A strict diet and intermittent fasting Sleeping at 5:00 PM with over eight hours of sleep Daily health tracking of organs and skin elasticity Weekly MRI scans and ultrasounds Guidance from over 30 doctors and health experts One notable act under this program included a plasma transfusion from his teenage son. The goal was to refresh his body using younger blood. Critics raised concerns, but Johnson viewed it as an experiment. According to his data, his biological age has decreased by more than five view of AI is not as a tool but as a pathway to extending human life. Bryan AI represents more than a program—it is a reflection of his own mind. His goal is to upload memory, personality, and thought into a digital system. This approach connects with a larger scientific field called mind uploading, where technology is used to preserve or replicate consciousness. Though many experts believe a digital copy cannot truly replace a human mind, Johnson disagrees. He sees brain functions as patterns that can be copied, understood, and replicated. Also Read: Bruce Willis Latest Health Update: Actor battles Frontotemporal Dementia. Here's all details about family, career, awards and net worth Johnson also leads Kernel, a neurotech company that is working on non-invasive brain helmets are designed to: Read brain activity in real time Help store or transfer memory Enable communication between human brains and machines To Johnson, biology is only the beginning. He refers to it as version 1.0, while digital life is version 2.0. This belief guides his work across all long-term goal is not just to live longer but to create a new form of existence where consciousness continues through data and view redefines mortality. He sees death not as unavoidable but as a technical challenge. His work aims to make continued existence the most important believes that if consciousness can be preserved or recreated, then death becomes a problem that can be solved, not just accepted. What is Bryan AI? Bryan AI is a digital replica of Bryan Johnson's consciousness, built using AI trained on his data, aimed at preserving his identity beyond his biological body. What is Project Blueprint? Project Blueprint is Bryan Johnson's $2 million-per-year program to reverse biological aging through strict routines, advanced medical scans, and expert health monitoring.
Time of India
a day ago
- Time of India
Will Bryan Johnson never die? Here's all about tech entrepreneur's tall claim, Bryan AI and Project Blueprint
What is Bryan AI? Think like him Respond like him Hold his values and memory Serve as a digital twin Live Events What is Project Blueprint? A strict diet and intermittent fasting Sleeping at 5:00 PM with over eight hours of sleep Daily health tracking of organs and skin elasticity Weekly MRI scans and ultrasounds Guidance from over 30 doctors and health experts AI and the Future of Human Consciousness Kernel and Real-Time Brain Mapping Read brain activity in real time Help store or transfer memory Enable communication between human brains and machines A New View of Existence and Death FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel In a recent WIRED interview, Johnson said he does not believe he will die. This statement is not based on belief alone but on scientific projects he is funding and leading. His work combines artificial intelligence, biology, and neuroscience to develop a new understanding of life and believes that human identity can move beyond biology. He is developing Bryan AI, a digital version of himself. This system is being trained using thousands of hours of his recorded conversations, writings, interviews, and to Johnson, Bryan AI will:This project reflects Johnson's idea that a person's consciousness can live beyond the body. He sees Bryan AI as a second version of himself, stored digitally and able to evolve personal health project, known as Project Blueprint, costs around $2 million per year. It focuses on reversing biological aging and is supported by a large medical features of his lifestyle include:One notable act under this program included a plasma transfusion from his teenage son. The goal was to refresh his body using younger blood. Critics raised concerns, but Johnson viewed it as an experiment. According to his data, his biological age has decreased by more than five view of AI is not as a tool but as a pathway to extending human life. Bryan AI represents more than a program—it is a reflection of his own goal is to upload memory, personality, and thought into a digital system. This approach connects with a larger scientific field called mind uploading , where technology is used to preserve or replicate many experts believe a digital copy cannot truly replace a human mind, Johnson disagrees. He sees brain functions as patterns that can be copied, understood, and also leads Kernel, a neurotech company that is working on non-invasive brain helmets are designed to:To Johnson, biology is only the beginning. He refers to it as version 1.0, while digital life is version 2.0. This belief guides his work across all long-term goal is not just to live longer but to create a new form of existence where consciousness continues through data and view redefines mortality. He sees death not as unavoidable but as a technical challenge. His work aims to make continued existence the most important believes that if consciousness can be preserved or recreated, then death becomes a problem that can be solved, not just AI is a digital replica of Bryan Johnson's consciousness, built using AI trained on his data, aimed at preserving his identity beyond his biological Blueprint is Bryan Johnson's $2 million-per-year program to reverse biological aging through strict routines, advanced medical scans, and expert health monitoring.
